Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.
作者： Harry G. Rittenhouse , Judith A. Finlay , Stephen D. Mikolajczyk , Alan W. Partin
DOI: 10.1080/10408369891234219
关键词:
摘要: … Future studies on both PSA and hK2 need to take into … to hK2 have now demonstrated that serum levels of hK2, like PSA, are correlated with prostate cancer. The production of hK2 …
elsevier.com
informapharmascience.com参考文章(421)
Geralyn M Lambert-Messerlian, Jacob A Canick, Dimitrios N Melegos, Eleftherios P Diamandis, Increased concentrations of prostate-specific antigen in maternal serum from pregnancies affected by fetal Down syndrome Clinical Chemistry. ,vol. 44, pp. 205- 208 ,(1998) , 10.1093/CLINCHEM/44.2.205
Mohammad S Saedi, Timothy M Hill, Kristine Kuus-Reichel, Abhay Kumar, Janice Payne, Stephen D Mikolajczyk, Robert L Wolfert, Harry G Rittenhouse, The precursor form of the human kallikrein 2, a kallikrein homologous to prostate-specific antigen, is present in human sera and is increased in prostate cancer and benign prostatic hyperplasia Clinical Chemistry. ,vol. 44, pp. 2115- 2119 ,(1998) , 10.1093/CLINCHEM/44.10.2115
A M Zhou, P C Tewari, B I Bluestein, G W Caldwell, F L Larsen, Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays. Clinical Chemistry. ,vol. 39, pp. 2483- 2491 ,(1993) , 10.1093/CLINCHEM/39.12.2483
Jens Dannull, Randhir Kaboo, Jean B. deKernion, Arie S. Belldegrun, Cho-Lea Tso, Kiarash Michel, Yiming Xie, Shen Pang, Identification of a Positive Regulatory Element Responsible for Tissue-specific Expression of Prostate-specific Antigen Cancer Research. ,vol. 57, pp. 495- 499 ,(1997)
R A Ferguson, H Yu, M Kalyvas, S Zammit, E P Diamandis, Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clinical Chemistry. ,vol. 42, pp. 675- 684 ,(1996) , 10.1093/CLINCHEM/42.5.675
D W Chan, D J Bruzek, J E Oesterling, R C Rock, P C Walsh, Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared. Clinical Chemistry. ,vol. 33, pp. 1916- 1920 ,(1987) , 10.1093/CLINCHEM/33.10.1916
D A Armbruster, Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clinical Chemistry. ,vol. 39, pp. 181- 195 ,(1993) , 10.1093/CLINCHEM/39.2.181
R L Vessella, Trends in immunoassays of prostate-specific antigen: serum complexes and ultrasensitivity. Clinical Chemistry. ,vol. 39, pp. 2035- 2039 ,(1993) , 10.1093/CLINCHEM/39.10.2035
G M Oremek, U B Seiffert, Physical activity releases prostate-specific antigen (PSA) from the prostate gland into blood and increases serum PSA concentrations. Clinical Chemistry. ,vol. 42, pp. 691- 695 ,(1996) , 10.1093/CLINCHEM/42.5.691
Eva Corey, Sandra K Wegner, Michael J Corey, Robert L Vessella, Prostate-specific antigen: characterization of epitopes by synthetic peptide mapping and inhibition studies. Clinical Chemistry. ,vol. 43, pp. 575- 584 ,(1997) , 10.1093/CLINCHEM/43.4.575